NDC 11673-267 – Guaifenesin and Dextromethorphan HBr

Guaifenesin 1200 mg/1; Dextromethorphan Hydrobromide 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC11673-267

Product details

Brand name
Guaifenesin and Dextromethorphan HBr
Generic name
Guaifenesin and Dextromethorphan HBr
Labeler
Target Corporation
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA206941
Marketed since
July 4, 2024
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Dextromethorphan HBr →

Package NDC codes (3)

Package NDCDescriptionSince
11673-267-051 BOTTLE in 1 CARTON (11673-267-05) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLEJul 4, 2024
11673-267-571 BOTTLE in 1 CARTON (11673-267-57) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLEJul 4, 2024
11673-267-601 BOTTLE in 1 CARTON (11673-267-60) / 42 TABLET, EXTENDED RELEASE in 1 BOTTLEJul 4, 2024

Other Guaifenesin and Dextromethorphan HBr products